BCAX
Bicara Therapeutics Inc.
17.60$
-3.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | +90.0% | +194.7% | – | |
| – | – | – | – | |
| – | -2.2% | +107.8% | +96.6% | |
| – | +46.2% | +102.4% | +62.5% | |
| – | +5.9% | +106.5% | +88.9% | |
| – | – | – | – | |
| – | -100.0% | – | – | |
| – | – | – | – | |
| – | +400.0% | +3,640.0% | +16.0% | |
| – | – | – | – | |
| – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.